Generic schizophrenia drug put to the test
NCT ID NCT07266792
Summary
This study tested if a new generic version of the schizophrenia drug Brexpiprazole works the same way in the body as the established brand-name version. It involved 36 healthy adults who each took both pills at different times. Researchers measured drug levels in the blood to see if they were equivalent.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for SCHIZOPHRENIA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Cliantha Research Limited
Ahmedabad, Gujarat, 382210, India
Conditions
Explore the condition pages connected to this study.